Clinical Trial

Safety and Performances of the LINEA Cardiac Pacing Lead Optimized for the Implantation in Interventricular Septum

Study acronym: STARLIGHT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the clinical investigation is to evaluate the safety and performances of the new LINEA cardiac pacing lead, intended for placement at the interventricular septum.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-05.
Trial Details
NCT Number NCT07342608
Lead Sponsor MicroPort CRM
Conditions Bradycardia, Left Bundle Branch Area Pacing, Left Bundle Branch Pacing
Enrollment 450 participants
Start Date 2026-03-31
Primary Completion 2027-01-31 (estimated)
Study Completion 2030-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-17